Impact of OSA primary therapy on antihypertensive drugs use - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles SLEEP Year : 2022

Impact of OSA primary therapy on antihypertensive drugs use

Abstract

No abstract available

Domains

Life Sciences [q-bio]

Danielle SALAS  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03807143

Submitted on : Sunday, October 9, 2022-12:13:27 PM

Last modification on : Friday, March 24, 2023-2:53:28 PM

Not file

Dates and versions

inserm-03807143 , version 1 (09-10-2022)

Identifiers

Cite

Bruno Revol, Christel Castelli, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of OSA primary therapy on antihypertensive drugs use. SLEEP, 2022, 45 (9), pp.zsac151. ⟨10.1093/sleep/zsac151⟩. ⟨inserm-03807143⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UGA CNRS DSP UNIV-MONTPELLIER
24 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More